Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Expert Opinion on Biological Therapy
Volume 23, 2023 - Issue 12
Drug Evaluation
Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency)
Tro Sekayana Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, San Diego, CA, USACorrespondence[email protected]
https://orcid.org/0009-0009-7050-0020View further author information
https://orcid.org/0009-0009-7050-0020View further author information, Dana H. Simmonsb Capitol Scientific, Washington DC, USAhttps://orcid.org/0000-0003-4852-4703View further author information
https://orcid.org/0000-0003-4852-4703View further author information & Annette von Drygalskia Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, San Diego, CA, USAhttps://orcid.org/0000-0002-9426-6322View further author information
https://orcid.org/0000-0002-9426-6322View further author information